Advertisement

Umbilical Cord and Its Blood: A Perspective on Its Current and Potential Use in Ophthalmology

  • Kyung-Chul Yoon
Chapter

Abstract

Recently, umbilical cord blood has been used in the treatment of various ocular surface diseases in ophthalmology. Umbilical cord blood contains essential tear components, growth factors, and neurotrophic factors such as epidermal growth factor, vitamin A, transforming growth factor-b, substance P, insulin-like growth factor, and nerve growth factor. Umbilical cord serum can provide basic nutrients for epithelial renewal and facilitate the proliferation, migration, and differentiation of the ocular surface epithelium. Serum eye drops made from umbilical cord blood can be used safely and effectively for the treatment of severe dry eye with or without Sjögren’s syndrome, ocular complications in graft-versus-host disease, persistent epithelial defects, and neurotrophic keratopathy.

Keywords

Umbilical Cord Blood Ocular Surface Autologous Serum Epithelial Defect Ocular Surface Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Esquenazi S, He J, Bazab HEP, Bazan NG. Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea. 2005;24:992-997.CrossRefPubMedGoogle Scholar
  2. 2.
    Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin. 2000;40:113-122.CrossRefPubMedGoogle Scholar
  3. 3.
    Fox RI, Chan R, Michelson JB, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984;27:459-461.CrossRefPubMedGoogle Scholar
  4. 4.
    Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren’s syndrome. Br J Ophthalmol. 1999;83:390-395.CrossRefPubMedGoogle Scholar
  5. 5.
    Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatrical pemphigoid and Steven-Johnson syndrome. Am J Ophthalmol. 1996;122:38-52.PubMedGoogle Scholar
  6. 6.
    Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eyedrops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2003;31:579-583.CrossRefPubMedGoogle Scholar
  7. 7.
    Noble BA, Loh RS, MacLennan S, et al. Comparison of autologous serum eye drops with conventional therapy in a randomized controlled crossover trial for ocular surface disease. Br J Ophthalmol. 2004;88:647-652.CrossRefPubMedGoogle Scholar
  8. 8.
    Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol. 2005;139:242-246.CrossRefPubMedGoogle Scholar
  9. 9.
    Tananuvat N, Daniell M, Suillivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea. 2001;20:802-806.CrossRefPubMedGoogle Scholar
  10. 10.
    Tsubota K, Goto E, Shimmura S, et al. Treatment of ­persistent epithelial defect by autologous serum application. Ophthalmology. 1999;106:1984-1989.CrossRefPubMedGoogle Scholar
  11. 11.
    Poon AC, Geerling G, Dart JK, et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85:1188-1197.CrossRefPubMedGoogle Scholar
  12. 12.
    Young AL, Cheng AC, Ng HK, et al. The use of autologous serum tears in persistent epithelial defect. Eye. 2004;18:609-614.CrossRefPubMedGoogle Scholar
  13. 13.
    Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111:1115-1120.CrossRefPubMedGoogle Scholar
  14. 14.
    Banker AS, Freeman WR, Azen SP, et al. A multicentered clinical study of serum as adjuvant therapy for surgical ­treatment of macular holes. Arch Ophthalmol. 1999;117:1499-1502.PubMedGoogle Scholar
  15. 15.
    Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 2001;20:807-810.CrossRefPubMedGoogle Scholar
  16. 16.
    del Castillo JM, de la Casa JM, Sardina RC, et al. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002;21:781-783.CrossRefPubMedGoogle Scholar
  17. 17.
    Schulze S, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol. 2006;142:207-211.CrossRefPubMedGoogle Scholar
  18. 18.
    Matsuo H, Tomidokoro A, Tomita G, Araie M. Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb. Eye. 2005;19:23-28.CrossRefPubMedGoogle Scholar
  19. 19.
    Vajpayee RB, Mukerji N, Tandon R, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol. 2003;87:1312-1316.CrossRefPubMedGoogle Scholar
  20. 20.
    Yoon KC, Heo H, Jeong IY, Park YG. Therapeutic effect of umbilical cord serum eydrops for persistent corneal epithelial defect. Korean J Ophthalmol. 2005;19:174-178.CrossRefPubMedGoogle Scholar
  21. 21.
    Yoon KC, Im SK, Park YG, et al. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea. 2006;25:268-272.CrossRefPubMedGoogle Scholar
  22. 22.
    Yoon KC, Jeong IY, Im SK, et al. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Bone Marrow Transplant. 2007;39:231-235.CrossRefPubMedGoogle Scholar
  23. 23.
    Yoon KC, You IC, Im SK, et al. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology. 2007;114:1637-1642.CrossRefPubMedGoogle Scholar
  24. 24.
    Yoon KC, Heo H, Im SK, et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. 2007;144:86-92.CrossRefPubMedGoogle Scholar
  25. 25.
    Geerling G, MacLennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88:1467-1474.CrossRefPubMedGoogle Scholar
  26. 26.
    Speek AJ, van Agtmaal EJ, Saowakontha S, et al. Fluorometric determination of retinol in human tear fluid using high-performance liquid chromatography. Curr Eye Res. 1986;5:841-845.CrossRefPubMedGoogle Scholar
  27. 27.
    Ohashi Y, Motokura M, Kinoshita Y, et al. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci. 1989;30:1879-1882.PubMedGoogle Scholar
  28. 28.
    Liu L, Hartwig D, Harloff S, et al. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol. 2005;243:706-714.CrossRefPubMedGoogle Scholar
  29. 29.
    Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1 [letter]. Arch Ophthalmol. 1997;115:926-927.PubMedGoogle Scholar
  30. 30.
    Chikama T, Fukuda K, Morishige N, Nishida T. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I [letter]. Lancet. 1998;351:1783-1784.CrossRefPubMedGoogle Scholar
  31. 31.
    Tan MH, Bryars J, Moore J. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Cornea. 2006;25:352-355.CrossRefPubMedGoogle Scholar
  32. 32.
    Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. New Eng J Med. 1998;338:1174-1180.CrossRefPubMedGoogle Scholar
  33. 33.
    Leite SC, de Castro RS, Alves M, et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2006;38:223-227.CrossRefPubMedGoogle Scholar
  34. 34.
    Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235-242.CrossRefPubMedGoogle Scholar
  35. 35.
    Choong PF, Mok PL, Cheong SK, Then KY. Mesenchymal stem cell-like characteristics of corneal keratocytes. Cytotherapy. 2007;9:252-258.CrossRefPubMedGoogle Scholar
  36. 36.
    Kioke-Kiriyama N, Adachi Y, Minamino K, et al. Human cord blood cells can differentiate into retinal nerve cells. Acta Neurobiol Exp (Wars). 2007;67:359-365.Google Scholar

Copyright information

© Springer London 2011

Authors and Affiliations

  1. 1.Department of OphthalmologyChonnam National University Medical School and HospitalGwang-JuSouth Korea

Personalised recommendations